- Home
- CLBR vs TERN Comparison
CLBR vs TERN Comparison
Compare CLBR & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLBR
- TERN
- Stock Information
- Founded
- CLBR 2023
- TERN 2017
- Country
- CLBR United States
- TERN United States
- Employees
- CLBR N/A
- TERN N/A
- Industry
- CLBR
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- CLBR
- TERN Health Care
- Exchange
- CLBR Nasdaq
- TERN Nasdaq
- Market Cap
- CLBR 304.5M
- TERN 262.9M
- IPO Year
- CLBR 2023
- TERN 2021
- Fundamental
- Price
- CLBR $13.79
- TERN $3.54
- Analyst Decision
- CLBR
- TERN Buy
- Analyst Count
- CLBR 0
- TERN 5
- Target Price
- CLBR N/A
- TERN $15.63
- AVG Volume (30 Days)
- CLBR 1.6M
- TERN 692.5K
- Earning Date
- CLBR 01-01-0001
- TERN 05-08-2025
- Dividend Yield
- CLBR N/A
- TERN N/A
- EPS Growth
- CLBR N/A
- TERN N/A
- EPS
- CLBR 0.19
- TERN N/A
- Revenue
- CLBR N/A
- TERN N/A
- Revenue This Year
- CLBR N/A
- TERN N/A
- Revenue Next Year
- CLBR N/A
- TERN N/A
- P/E Ratio
- CLBR $74.94
- TERN N/A
- Revenue Growth
- CLBR N/A
- TERN N/A
- 52 Week Low
- CLBR $10.15
- TERN $1.87
- 52 Week High
- CLBR $17.47
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- CLBR 50.85
- TERN 67.52
- Support Level
- CLBR $13.81
- TERN $3.01
- Resistance Level
- CLBR $17.47
- TERN $3.60
- Average True Range (ATR)
- CLBR 1.23
- TERN 0.21
- MACD
- CLBR -0.04
- TERN 0.06
- Stochastic Oscillator
- CLBR 19.72
- TERN 91.33
About CLBR Colombier Acquisition Corp. II
Colombier Acquisition Corp II is a blank check company.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.